Detalhe da pesquisa
1.
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
Ann Intern Med
; 171(10): 685-694, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610549
2.
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
J Virol
; 92(5)2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212942
3.
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.
Nanomedicine
; 14(2): 339-351, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29157976
4.
The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
Retrovirology
; 14(1): 50, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29121950
5.
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.
J Antimicrob Chemother
; 72(3): 829-836, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999018
6.
Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
Ann Rheum Dis
; 76(9): 1575-1582, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450313
7.
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.
PLoS Pathog
; 11(12): e1005270, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26633181
8.
Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study.
J Neurovirol
; 23(5): 679-685, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28718069
9.
Letter to the Editor on the original article: Lower prevalence of congenital cytomegalovirus infection in Portugal: possible impact of COVID-19 lockdown?
Eur J Pediatr
; 181(3): 1293-1294, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091799
10.
Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.
Immunol Cell Biol
; 94(7): 689-700, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26987686
11.
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
J Virol
; 89(22): 11557-71, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355081
12.
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
J Virol
; 89(18): 9189-99, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109727
13.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
J Antimicrob Chemother
; 70(6): 1833-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724985
14.
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
J Virol
; 88(22): 12992-3004, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25165114
15.
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
NPJ Vaccines
; 9(1): 53, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448450
16.
Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.
AIDS Res Hum Retroviruses
; 39(5): 211-221, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416229
17.
Immunological and virological findings in a patient with exceptional post-treatment control: a case report.
Lancet HIV
; 10(1): e42-e51, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36354046
18.
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
Vaccines (Basel)
; 11(2)2023 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851164
19.
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
Vaccines (Basel)
; 12(1)2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250827
20.
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
NPJ Vaccines
; 8(1): 147, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775521